Sigal Manor

Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0

Carolyn Katovich Hurley, Jane Kempenich, Kim Wadsworth et al. · HLA · 2020 · 169 citations · Full text

Life Sciences, Genetics, Hematology +17

Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?

Eva Froňková, Ester Mejstříková, Smadar Avigad et al. · Leukemia · 2008 · 73 citations

Medicine, Pediatrics, Diagnostic Imaging +8

MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population

Shay Ben Shachar, Noam Barda, Sigal Manor et al. · Journal of Clinical Immunology · 2021 · 45 citations · Full text

Life Sciences, Genetics, Immunology +17

Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T‐cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real‐time quantitative polymerase chain reaction (RQ‐PCR)

Batia Stark, Smadar Avigad, Drorit Luria et al. · Pediatric Blood & Cancer · 2008 · 36 citations · Full text

Medicine, Hematology, Oncology +17

High-resolution HLA A∼B∼DRB1 haplotype frequencies from the Ezer Mizion Bone Marrow Donor Registry in Israel

Sigal Manor, Michael Halagan, Nira Shriki et al. · Human Immunology · 2016 · 17 citations

Life Sciences, Hematology, Immunology +12